题目内容
“近朱者赤，近墨者黑”这句话反映了（）因素对人发展的影响。
查看答案
搜索结果不匹配？点我反馈
更多问题
Passage FourThe "issues" reported were unthinkable. The physician who enrolled the most patients in the study, an Alabama weight-loss doctor, allegedly forged scores of signatures, enrolling "’volunteers" every few minutes. By the time of the FDA review, she was under criminal investigation. (She’s now in federal prison.) Another key researcher had been put on probation by the California medical board for gross negligence. He was arrested shortly after the study ended, when police, called to his home on a domestic violence complaint, found him with a bag of cocaine and waving a loaded gun at imaginary people. The study was so riddled with fraud and error that FDA reviewers decided it was useless. Yet Dr. Ross says he was told to reveal nothing about those problems to the advisory board, which recommended that the drug be approved. Later, he says, he was pressured to soften his report about Ketek’s liver toxicity to gain approval of higher-ups. Six million Americans have now used the drug, including hundreds of infants in a clinical trial designed to test Ketek’s effectiveness against ear infections. "How does one justify balancing the risk of fatal liver failure against one day less of ear pain" one FDA scientist, Rosemary Johann-Liang, protested--to no avail--in a memo to her superiors. Most ear infections clear up in a few days on their own, she says. The agency says the controversy is overblown. "There was enough good, solid scientific data to make that decision." Says FDA spokeswoman Julie Zawisza, pointing to what appeared to be a history of safe use of Ketek in other countries. Ketek has now been linked to 18 deaths and at least 134 cases of liver damage, according to an independent analysis using FDA data. The real toll, some researchers say, may be far greater. Last October the FDA sent a warning letter to Sanofi-Aventis, Ketek’s maker, accusing the company of knowingly presenting compromised data to the agency, a charge the company denies. "We were not aware of the fraud," says spokeswoman Melissa Feltmann. "It was not until the FDA’s criminal investigators uncovered it that we became aware of it." The question remains, What did the FDA and the drugmaker know about the fake safety data, and when Congressmen John Dingell and Bart Stupak, both Michigan Democrats, are investigating that mystery right now in Congressional hearings. "Unfortunately," Stupak says, "the truth comes too late for some victims." FDA suspected Sanofi-Aventis of（）
某校初三年级有位叫王峰的学生，经常迟到、旷课、上游戏厅，甚至打架、敲竹杠。学习成绩就更不用说了，门门功课挂红灯，尽管老师多次教育，仍不见好转，还是经常旷课、打游戏、向同学借钱，同学不借就打同学，以致班里同学见了他都躲得远远的。虽然偶尔也有进步，但没过两天又恢复原样了，以致老师对他失去了信心。教师的这种做法不符合教师职业道德规范中的（）。
Passage FourThe "issues" reported were unthinkable. The physician who enrolled the most patients in the study, an Alabama weight-loss doctor, allegedly forged scores of signatures, enrolling "’volunteers" every few minutes. By the time of the FDA review, she was under criminal investigation. (She’s now in federal prison.) Another key researcher had been put on probation by the California medical board for gross negligence. He was arrested shortly after the study ended, when police, called to his home on a domestic violence complaint, found him with a bag of cocaine and waving a loaded gun at imaginary people. The study was so riddled with fraud and error that FDA reviewers decided it was useless. Yet Dr. Ross says he was told to reveal nothing about those problems to the advisory board, which recommended that the drug be approved. Later, he says, he was pressured to soften his report about Ketek’s liver toxicity to gain approval of higher-ups. Six million Americans have now used the drug, including hundreds of infants in a clinical trial designed to test Ketek’s effectiveness against ear infections. "How does one justify balancing the risk of fatal liver failure against one day less of ear pain" one FDA scientist, Rosemary Johann-Liang, protested--to no avail--in a memo to her superiors. Most ear infections clear up in a few days on their own, she says. The agency says the controversy is overblown. "There was enough good, solid scientific data to make that decision." Says FDA spokeswoman Julie Zawisza, pointing to what appeared to be a history of safe use of Ketek in other countries. Ketek has now been linked to 18 deaths and at least 134 cases of liver damage, according to an independent analysis using FDA data. The real toll, some researchers say, may be far greater. Last October the FDA sent a warning letter to Sanofi-Aventis, Ketek’s maker, accusing the company of knowingly presenting compromised data to the agency, a charge the company denies. "We were not aware of the fraud," says spokeswoman Melissa Feltmann. "It was not until the FDA’s criminal investigators uncovered it that we became aware of it." The question remains, What did the FDA and the drugmaker know about the fake safety data, and when Congressmen John Dingell and Bart Stupak, both Michigan Democrats, are investigating that mystery right now in Congressional hearings. "Unfortunately," Stupak says, "the truth comes too late for some victims." It can be inferred that Ketek is a medicine which（）
进口报关单
微信支付 
支付宝支付